Home › Therapeutic areas › GI/Hepatology › Short Bowel Syndrome
Short Bowel Syndrome (1 companies)
Companies with an active program in Short Bowel Syndrome.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| ENTX | Entera Bio | GI/HepatologyMetabolic Rare | 1 | Phase 2 | $547M | 4 |
No companies match.